当前位置:首页 - 行情中心 - 万邦医药(301520) - 财务分析 - 资产负债表

万邦医药

(301520)

  

流通市值:9.37亿  总市值:28.31亿
流通股本:2207.34万   总股本:6666.67万

资产负债表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
流动资产:
  货币资金57,996,749.28150,297,730.0460,946,286.772,313,777.53
  结算备付金-000
  拆出资金-000
  交易性金融资产1,082,718,946.681,000,718,794.891,100,794,578.31,105,187,391.54
  衍生金融资产-000
  应收票据及应收账款73,627,295.0684,417,948.0864,548,259.0783,593,834.49
  其中:应收票据3,844,071.83,092,9004,021,768.064,059,360.98
        应收账款69,783,223.2681,325,048.0860,526,491.0179,534,473.51
  应收款项融资0240,27000
  预付款项13,253,796.58,528,043.5211,502,053.998,448,464.76
  其他应收款合计3,275,804.822,073,081.427,034,124.896,854,001.69
  存货1,322,207.01871,291.85963,381.38983,972.82
  合同资产112,735,215.81106,856,965.31111,476,027.7997,717,668.47
  其他流动资产6,130,162.26,148,328.325,905,873.696,004,132.5
  流动资产合计1,351,060,177.361,360,152,453.431,363,170,585.811,381,103,243.8
非流动资产:
  其他权益工具投资0010,000,0000
  其他非流动金融资产27,000,00024,000,0003,000,0003,000,000
  投资性房地产6,495,738.566,593,601.776,691,464.986,789,328.19
  固定资产159,919,915.56163,663,170.09165,549,963.29168,362,888.44
  在建工程44,921,682.1336,973,015.0128,888,304.5319,815,296.17
  无形资产9,711,509.269,916,192.9610,849,910.7311,121,935.91
  长期待摊费用952,785.64849,947.022,066,287.181,267,736.48
  递延所得税资产80,468.2631,730.55529,785.66345,337.48
  其他非流动资产769,307.9346,331.39412,207.28480,699.85
  非流动资产合计249,851,407.31242,373,988.79227,987,923.65211,183,222.52
  资产总计1,600,911,584.671,602,526,442.221,591,158,509.461,592,286,466.32
流动负债:
  短期借款-000
  向中央银行借款-000
  吸收存款及同业存放-000
  拆入资金-000
  交易性金融负债-000
  衍生金融负债-000
  应付票据及应付账款28,313,512.7233,419,430.0932,247,801.9740,020,120.6
  其中:应付票据-000
        应付账款28,313,512.7233,419,430.0932,247,801.9740,020,120.6
  预收款项-000
  合同负债27,611,141.7319,084,672.0316,490,152.3817,908,914
  卖出回购金融资产款-000
  应付手续费及佣金-000
  应付职工薪酬5,425,855.086,791,062.1910,001,208.917,940,441.25
  应交税费657,640.34594,104.46739,132.92875,327.69
  其他应付款合计2,419,510.052,214,083.632,067,713.171,988,203.06
  其中:应付利息-000
        应付股利-000
  应付分保账款-000
  保险合同准备金-000
  代理买卖证券款-000
  代理承销证券款-000
  一年内到期的非流动负债-000
  其他流动负债1,153,356.493,335,022.19818,518.851,058,534.54
  流动负债合计65,581,016.4165,438,374.5962,364,528.269,791,541.14
非流动负债:
  长期借款-000
  应付债券-000
  优先股-000
  永续债-000
  租赁负债-000
  长期应付款-000
  长期应付职工薪酬-000
  预计负债5,000,0005,000,00000
  递延收益9,452,365.859,902,958.9210,339,167.3910,775,435.72
  递延所得税负债5,243,819.556,788,956.085,688,721.916,634,828.07
  其他非流动负债-000
  非流动负债合计19,696,185.421,691,91516,027,889.317,410,263.79
  负债合计85,277,201.8187,130,289.5978,392,417.587,201,804.93
所有者权益(或股东权益):
  实收资本(或股本)66,666,66766,666,66766,666,66766,666,667
  其他权益工具-000
  优先股-000
  永续债-000
  资本公积1,039,115,331.011,038,615,318.621,039,309,092.41,037,926,875.57
  减:库存股15,233,43815,233,43815,233,43815,233,438
  其他综合收益-000
  专项储备-000
  盈余公积40,526,803.3840,526,803.3840,526,803.3840,526,803.38
  一般风险准备-000
  未分配利润384,559,019.47384,820,801.63381,496,967.18375,197,753.44
  归属于母公司股东权益合计1,515,634,382.861,515,396,152.631,512,766,091.961,505,084,661.39
  少数股东权益-000
  股东权益合计1,515,634,382.861,515,396,152.631,512,766,091.961,505,084,661.39
  负债和股东权益合计1,600,911,584.671,602,526,442.221,591,158,509.461,592,286,466.32
公告日期2026-04-232026-04-232025-10-232025-08-26
审计意见(境内)标准无保留意见
TOP↑